Featured Toolkit
Sharp Injury & Needlestick Prevention Toolkit
Needle sticks and sharps injuries are among the most common workplace injuries in the healthcare industry. One of the...
Learn MoreToolkits
Browse our extensive toolkit library for helpful tips, tools and resources designed to make your job easier!
Our toolkits are your one-stop-shop for information pertinent to improving processes, identifying best practices, reducing risks, obtaining education information, and much more.
Have an idea or a specific need for a toolkit you don’t see listed here? Please contact Vice President of Patient Safety & Risk Stacie Jenkins at staciejenkins@lhatrustfunds.com to share your suggestion.
Featured Toolkit
Needle sticks and sharps injuries are among the most common workplace injuries in the healthcare industry. One of the...
Learn More445-446 out of 32
Louisiana residents who use TM are required to purchase it from an approved Louisiana marijuana provider. The TM packaging must have the original label indicating it is a Louisiana product. These are photos of the Louisiana TM product produced by the LSU Ag Center.
Sample language to develop an acknowledgment for the caregivers of patients who use TM while admitted to the organization. This language serves as an understanding between the caregiver and the organization that the administration of TM will be conducted appropriately and according to Louisiana law.
Sample patient consent to treatment with TM. This policy is most applicable to the physician office practice where the physician has been approved by LSBME to recommend TM. This language can be customized for your organization. The policy outlines side effects, risks and other important information regarding the medication.
This document, provided by the National Council of State Boards of Nursing, provides guidance to Boards of Nursing on assessment and decision making on issues related to marijuana. These guidelines address licensees who test positive for THC or metabolites, improper certifying of medical marijuana program qualifying conditions, and licensee’s administration of marijuana outside of a therapeutic marijuana program.
Medication errors can occur at any point in the medication delivery system. These guidelines provide the pharmacist with practical recommendations and best practices for preventing and mitigating patient harm from medication errors.
This policy statement, developed by the American Academy of Pediatrics, addresses medication errors in the pediatric population. The statement outlines safeguards that should be taken for pediatric patients, going above and beyond those for adults.
445-450 out of 777
445-449 out of 137